Inner Cosmos is a neurotechnology startup founded by Meron Gribetz that has developed a tiny neural implant it calls “a digital pill for the mind.” The device is similar to a cochlear implant and is roughly the size of a fingernail; it is implanted under the skin and sits unobtrusively next to the skull. A separate “prescription pod” snaps onto the hair to power the implant, while clinicians program and tune therapy remotely via a dashboard. Sensors constantly monitor the implant so doctors can check patients’ brain activity in real time. The company presented this first neural implant to treat depression and says the system later will also treat other cognitive disorders. Inner Cosmos recently received FDA Investigational Device Exemption approval to conduct its first human study and closed a $10 million seed funding round.

Total raised

$10M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2022